Assessing the efficacy and safety in novel drug candidates for Alzheimer's disease requires a rigorous evaluation process. Preclinical studies usually involve in vitro and in vivo models to assess its potential effectiveness in targeting disease-related pathways. Once promising candidates emerge, they undergo clinical trials that are conducted wit